Disproportional analysis of adverse reactions of tepotinib based on FDA adverse event reporting system database

doi:10.3969/j.issn.1672-3384.2025.08.012

Mengyang WANG, Bin DONG, Xinyan LI, Zhihong WANG, Guohui LI

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (8) : 67-73.

PDF(504 KB)

Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (8) : 67-73. DOI: 10.3969/j.issn.1672-3384.2025.08.012

Original Article

Disproportional analysis of adverse reactions of tepotinib based on FDA adverse event reporting system database

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 23(8): 67-73 https://doi.org/10.3969/j.issn.1672-3384.2025.08.012

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(504 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2025-04-30	2025-08-10
Issue Date
2025-08-27

Please choose a citation manager

Content to export